accountTEL AVIV (MarketWatch) -- Allergan Inc. won a ruling in federal court that its patents on Alphagan, which lowers pressure in the eye in patients with open-angle glaucoma and ocular hypertension, were infringed. The ruling...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Allergan wins ruling in patent dispute
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
